FDA approves empagliflozin for HFrEF | A 'concerning' trend | Taking a close look at healthcare spending

The FDA’s decision was based largely on results from a clinical trial that included more than 3,700 heart failure patients with a left ventricular ejection fraction of 40% or less.

Conflicts of interest and undisclosed financial associations may pose a problem for many medical journals.

Researchers tracked data from more than 49,000 patients who underwent LAAO from January 2016 to June 2019.

“Measuring healthcare spending by race and ethnicity is important for understanding patterns in utilization and treatment,” researchers said.

The FDA has requested additional data before approving roxadustat.

“Our study demonstrates that a centrally guided and well-designed healthcare policy may have a real and substantial impact on a patient’s prognosis over a relatively short period of time,” researchers said.

Ablation was associated with a 67% reduction in all-cause hospitalizations compared to medication alone. 

Cerebrovascular accidents following PCI appear to be more common when the patient has a history of recent marijuana use. 

Clinicians can use the tool to automatically quantify, outline and measure brain abnormalities during emergency situations.

Technology educators, tech-policy wonks and hospital clinical leaders from three countries have collaborated to produce a helpful guide for end-users of healthcare-specific AI tools—and the patients they serve.